Aspiring Ventures »

Immunitybio shares owned by Aspiring Ventures

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Aspiring Ventures from 13F filings

Historical chart of Aspiring Ventures investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Aspiring Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Aspiring Ventures

Quarter filed Position value Share count Share price at filing
2026-06-30 $184k 21k 8.76

More positions owned by Aspiring Ventures

Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Strategy Cl A New Call Option (MSTR)
Echostar Corp Cl A
Asml Hldg Nv N Y Registry Shs (ASML)
Planet Labs Pbc Com Cl A (PL)
Amazon (AMZN)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Strategy Series A Perp Pf (STRK)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Palantir Technologies Cl A (PLTR)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Schwab Strategic Tr Fundamental Us B (FNDB)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)

View all positions for Aspiring Ventures

Top funds holding Immunitybio

BlackRock
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
D. E. Shaw & Co
Two Sigma Investments
Geode Capital Management
Susquehanna International
Citadel Advisors
Millennium Management
LMR Partners
Morgan Stanley
Northern Trust
Goldman Sachs Group
UBS Group

View all funds holding Immunitybio